127 related articles for article (PubMed ID: 36731031)
1. Metabolomic Profiling of Recombinant Erythropoietin (rHuEpo) in Trained Caucasian Athletes.
Lima G; Shurlock J; Wang G; Karanikolou A; Sutehall S; Pitsiladis YP; D'Alessandro A
Clin J Sport Med; 2023 Sep; 33(5):e123-e134. PubMed ID: 36731031
[TBL] [Abstract][Full Text] [Related]
2. Blood transcriptional signature of recombinant human erythropoietin administration and implications for antidoping strategies.
Durussel J; Haile DW; Mooses K; Daskalaki E; Beattie W; Mooses M; Mekonen W; Ongaro N; Anjila E; Patel RK; Padmanabhan N; McBride MW; McClure JD; Pitsiladis YP
Physiol Genomics; 2016 Mar; 48(3):202-9. PubMed ID: 26757800
[TBL] [Abstract][Full Text] [Related]
3. Effects of EPO on Blood Parameters and Running Performance in Kenyan Athletes.
Haile DW; Durussel J; Mekonen W; Ongaro N; Anjila E; Mooses M; Daskalaki E; Mooses K; McClure JD; Sutehall S; Pitsiladis YP
Med Sci Sports Exerc; 2019 Feb; 51(2):299-307. PubMed ID: 30188362
[TBL] [Abstract][Full Text] [Related]
4. Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.
Wang G; Durussel J; Shurlock J; Mooses M; Fuku N; Bruinvels G; Pedlar C; Burden R; Murray A; Yee B; Keenan A; McClure JD; Sottas PE; Pitsiladis YP
BMC Genomics; 2017 Nov; 18(Suppl 8):817. PubMed ID: 29143667
[TBL] [Abstract][Full Text] [Related]
5. Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.
Durussel J; Daskalaki E; Anderson M; Chatterji T; Wondimu DH; Padmanabhan N; Patel RK; McClure JD; Pitsiladis YP
PLoS One; 2013; 8(2):e56151. PubMed ID: 23418527
[TBL] [Abstract][Full Text] [Related]
6. Hyperhydration Effect on Pharmacokinetic Parameters and Detection Sensitivity of Recombinant Human Erythropoietin in Urine and Serum Doping Control Analysis of Males.
Athanasiadou I; Dokoumetzidis A; Voss SC; El Saftawy W; Al-Maadheed M; Valsami G; Georgakopoulos C
J Pharm Sci; 2019 Jun; 108(6):2162-2172. PubMed ID: 30684541
[TBL] [Abstract][Full Text] [Related]
7. Detection of recombinant human erythropoietin in urine by isoelectric focusing.
Breidbach A; Catlin DH; Green GA; Tregub I; Truong H; Gorzek J
Clin Chem; 2003 Jun; 49(6 Pt 1):901-7. PubMed ID: 12765986
[TBL] [Abstract][Full Text] [Related]
8. Possible indirect detection of rHuEPO administration in human urine by high-performance liquid chromatography tandem mass spectrometry.
Appolonova SA; Dikunets MA; Rodchenkov GM
Eur J Mass Spectrom (Chichester); 2008; 14(3):201-9. PubMed ID: 18708700
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.
Heuberger JAAC; van Eenoo P; Rotmans JI; Gal P; Stuurman FE; Post TE; Daniels JMA; Ram H; de Hon O; Burggraaf J; Cohen AF
Drug Test Anal; 2019 Sep; 11(9):1290-1301. PubMed ID: 31232530
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
[TBL] [Abstract][Full Text] [Related]
11. Detection of the administration of human erythropoietin (HuEPO) to canines.
Bartlett C; Clancy GJ; Cowan DA; Healy JF
J Anal Toxicol; 2006; 30(9):663-9. PubMed ID: 17137526
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in physiology and haematology in response to high- and micro-doses of recombinant human erythropoietin.
Clark B; Woolford SM; Eastwood A; Sharpe K; Barnes PG; Gore CJ
Drug Test Anal; 2017 Oct; 9(10):1561-1571. PubMed ID: 28214385
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
[TBL] [Abstract][Full Text] [Related]
14. Additive effect of erythropoietin use on exercise-induced endothelial activation and hypercoagulability in athletes.
Heuberger JAAC; Posthuma JJ; Ziagkos D; Rotmans JI; Daniels JMA; Gal P; Stuurman FE; Spronk HMH; Ten Cate H; Burggraaf J; Moerland M; Cohen AF
Eur J Appl Physiol; 2020 Aug; 120(8):1893-1904. PubMed ID: 32537688
[TBL] [Abstract][Full Text] [Related]
15. Monitoring recombinant human erythropoietin abuse among athletes.
Citartan M; Gopinath SCB; Chen Y; Lakshmipriya T; Tang TH
Biosens Bioelectron; 2015 Jan; 63():86-98. PubMed ID: 25058943
[TBL] [Abstract][Full Text] [Related]
16. Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing.
Lundby C; Achman-Andersen NJ; Thomsen JJ; Norgaard AM; Robach P
J Appl Physiol (1985); 2008 Aug; 105(2):417-9. PubMed ID: 18583375
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes : a population approach.
Gaudard A; Varlet-Marie E; Audran M; Gomeni R; Bressolle F
Clin Drug Investig; 2003; 23(3):167-79. PubMed ID: 23340923
[TBL] [Abstract][Full Text] [Related]
18. Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.
Hahn D; Cody JD; Hodson EM
Cochrane Database Syst Rev; 2014 May; 2014(5):CD003895. PubMed ID: 24872328
[TBL] [Abstract][Full Text] [Related]
19. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
Allegra V; Martimbianco L; Vasile A
Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
